Amir Axelrod, MD | |
Unm Hospital Internal Medicine, 2211 Lomas Blvd Ne, Albuquerque, NM 87131-0001 | |
(505) 272-6225 | |
Not Available |
Full Name | Amir Axelrod |
---|---|
Gender | Male |
Speciality | Cardiovascular Disease (cardiology) |
Experience | 23 Years |
Location | Unm Hospital Internal Medicine, Albuquerque, New Mexico |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1174662175 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RC0000X | Internal Medicine - Cardiovascular Disease | 2004-0299 (New Mexico) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Kaiser Foundation Hospital And Rehab Center | Vallejo, CA | Hospital |
Kaiser Foundation Hospital - Vacaville | Vacaville, CA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Permanente Medical Group Inc | 8921910225 | 7800 |
News Archive
Independent investigators reported today that patients with paroxysmal nocturnal hemoglobinuria who were treated long-term with Soliris (eculizumab) achieved survival comparable to that of an age- and gender-matched normal population. Findings from this investigator-led analysis were reported in an oral presentation today at the 52nd American Society of Hematology Annual Meeting and Exposition in Orlando.
Selecting the right packaging to get precious cargo from point A to point B can be a daunting task at the post office. For some time, scientists have wrestled with a similar set of questions when packaging medicine for delivery in the bloodstream:
Scientists at The Scripps Research Institute and Scripps Clinic have received a grant of nearly $2.4 million from the California Institute for Regenerative Medicine to support safety and quality tests of a potential stem cell therapy for Parkinson's disease.
Cardiome Pharma Corp. today announced the approval of BRINAVESS for reimbursement by Belgium's national compulsory health care and benefits insurance authority, The National Institute for Health and Disability Insurance (Institut National d'Assurance Maladie Invalidité or INAMI). As a result of this decision, BRINAVESS is expected to be listed for reimbursement in Belgium as of June 1, 2015.
"World Bank President Robert Zoellick on Wednesday called on economists to rethink the way they look at issues affecting developing nations and said he was overhauling the way his institution approached research," Reuters reports (Wroughton, 9/29).
› Verified 3 days ago
Entity Name | Permanente Medical Group Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1073606299 PECOS PAC ID: 8921910225 Enrollment ID: O20031104000710 |
News Archive
Independent investigators reported today that patients with paroxysmal nocturnal hemoglobinuria who were treated long-term with Soliris (eculizumab) achieved survival comparable to that of an age- and gender-matched normal population. Findings from this investigator-led analysis were reported in an oral presentation today at the 52nd American Society of Hematology Annual Meeting and Exposition in Orlando.
Selecting the right packaging to get precious cargo from point A to point B can be a daunting task at the post office. For some time, scientists have wrestled with a similar set of questions when packaging medicine for delivery in the bloodstream:
Scientists at The Scripps Research Institute and Scripps Clinic have received a grant of nearly $2.4 million from the California Institute for Regenerative Medicine to support safety and quality tests of a potential stem cell therapy for Parkinson's disease.
Cardiome Pharma Corp. today announced the approval of BRINAVESS for reimbursement by Belgium's national compulsory health care and benefits insurance authority, The National Institute for Health and Disability Insurance (Institut National d'Assurance Maladie Invalidité or INAMI). As a result of this decision, BRINAVESS is expected to be listed for reimbursement in Belgium as of June 1, 2015.
"World Bank President Robert Zoellick on Wednesday called on economists to rethink the way they look at issues affecting developing nations and said he was overhauling the way his institution approached research," Reuters reports (Wroughton, 9/29).
› Verified 3 days ago
Mailing Address | Practice Location Address |
---|---|
Amir Axelrod, MD 2211 Lomas Blvd Ne, Msc 084770, Albuquerque, NM 87106-2719 Ph: (505) 272-6225 | Amir Axelrod, MD Unm Hospital Internal Medicine, 2211 Lomas Blvd Ne, Albuquerque, NM 87131-0001 Ph: (505) 272-6225 |
News Archive
Independent investigators reported today that patients with paroxysmal nocturnal hemoglobinuria who were treated long-term with Soliris (eculizumab) achieved survival comparable to that of an age- and gender-matched normal population. Findings from this investigator-led analysis were reported in an oral presentation today at the 52nd American Society of Hematology Annual Meeting and Exposition in Orlando.
Selecting the right packaging to get precious cargo from point A to point B can be a daunting task at the post office. For some time, scientists have wrestled with a similar set of questions when packaging medicine for delivery in the bloodstream:
Scientists at The Scripps Research Institute and Scripps Clinic have received a grant of nearly $2.4 million from the California Institute for Regenerative Medicine to support safety and quality tests of a potential stem cell therapy for Parkinson's disease.
Cardiome Pharma Corp. today announced the approval of BRINAVESS for reimbursement by Belgium's national compulsory health care and benefits insurance authority, The National Institute for Health and Disability Insurance (Institut National d'Assurance Maladie Invalidité or INAMI). As a result of this decision, BRINAVESS is expected to be listed for reimbursement in Belgium as of June 1, 2015.
"World Bank President Robert Zoellick on Wednesday called on economists to rethink the way they look at issues affecting developing nations and said he was overhauling the way his institution approached research," Reuters reports (Wroughton, 9/29).
› Verified 3 days ago
Dr. Alberto Aguayo Rico, M.D, Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 401 San Mateo Blvd Se, Albuquerque, NM 87108 Phone: 505-462-7333 Fax: 505-462-7440 | |
Peter Guido, MD Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 4700 Jefferson St Ne, Ste 800, Albuquerque, NM 87109 Phone: 505-872-6000 Fax: 505-872-6003 | |
Kenneth A Bell, DO Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 2901 Transport St Se, Albuquerque, NM 87106 Phone: 505-262-7110 Fax: 505-262-7308 | |
Joseph F. Oser, M.D. Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 1501 San Pedro Dr Se, Albuquerque, NM 87108 Phone: 505-265-1711 | |
Dr. Stanley Zissman Berman, M.D. Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 7416 Vista Del Arroyo Ave Ne, Albuquerque, NM 87109 Phone: 505-884-7270 | |
Huyentrang Vu, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: Unm Hospital Internal Medicine, 2211 Lomas Blvd Ne, Albuquerque, NM 87131 Phone: 505-272-6225 | |
Tamara Goodman, MD Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 4901 Lang Ave Ne, Albuquerque, NM 87109 Phone: 505-842-8171 |